R.PR
REGISTERED-PRINCIPAL REGISTER
11/23/2021
Back to search
Official data from USPTO
IMMODULON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMODULON
ST13
US500000088354623Class
5, 42, 44
Filing
88354623
Registration
6564939
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/29/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/25/2019
Registration date
11/23/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/23/2021
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
MIZELLE HOWARD, DEZMONA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immodulon Therapeutics Limited
Representatives
Alexandra MacKay STITES & HARBISON, PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; immune modulatorspharmaceutical preparations for treatment of immune system related diseasesdisordersdysregulation; vitamins and vitamin preparations
Class 42
Scientific and technological services and research and design relating theretoresearch and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research servicesresearch relating to immune system related diseases and disorders; clinical research in the field of medical sciencemedical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discoverydrug discovery productspharmaceuticalsmedicinal diagnosticsbiological productsmedical apparatusdevices and instrumentspharmaceutical drug development services; supply of information in the area of laboratory technologyproviding technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portalsproviding scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; scientific consultancyconsulting services in the field of the research and development of immunotherapy productspharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; consultancy and research in the fields of science and technologyresearch in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic serviceslaboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technologyproviding an on-line computer database in the field of medical and scientific research of immune dysregulation
Class 44
Medical and therapeutic servicestreatment of patients with immuno disorders; medicalhygienic and beauty care for human beings; provision of medical information; advisory services relating to medical servicespreparations and apparatusproviding medical informationconsultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of healthproviding an on-line computer database featuring information regarding health and nutrition
Publications
History of USPTO decisions and trademark events.
38 publications found
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/19/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/19/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/05/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2021
EX1G
SOU EXTENSION 1 GRANTED
04/30/2021
EXT1
SOU EXTENSION 1 FILED
04/30/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/30/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/15/2020
PUBO
PUBLISHED FOR OPPOSITION
09/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/12/2020
ALIE
ASSIGNED TO LIE
08/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2020
DMCC
DATA MODIFICATION COMPLETED
08/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/05/2020
GNRT
NON-FINAL ACTION E-MAILED
02/05/2020
CNRT
NON-FINAL ACTION WRITTEN
02/05/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/31/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/23/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/23/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2019
GNRT
NON-FINAL ACTION E-MAILED
06/10/2019
CNRT
NON-FINAL ACTION WRITTEN
06/10/2019
DOCK
ASSIGNED TO EXAMINER
06/05/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/06/2019
ALIE
ASSIGNED TO LIE
05/06/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2019
NWAP
NEW APPLICATION ENTERED
03/28/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMODULON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.